Tag: Liver Disease: Misc.
Prevalence of Alcohol-Related Liver Fibrosis More Than Doubled Over Last 20 Years
1999-2004 to 2013-2020 saw increase in prevalence of high FIB-4 from 1.8 to 4.3 percent, despite no increase in alcohol use
Increased Liver Enzyme Levels Seen With Use of Cannabidiol in Adults
Cannabidiol within the range consumers are taking with unregulated products linked to increase in liver enzymes
Metabolic Dysfunction-Associated Steatotic Liver Disease Linked to Risk for Sudden Hearing Loss
MASLD linked to increased risk for sudden sensorineural hearing loss
Waist-to-Height Ratio Predicts Liver Steatosis and Fibrosis
Waist-to-height ratio outperforms body mass index-indicated obesity
Alcoholic Liver Disease Mortality Increased Across Demographic Groups
More rapid increases in ALD mortality seen for women than men, and a concerning trend seen for young adults
Dapagliflozin Beneficial for Improving MASH Without Worsening Fibrosis
Dapagliflozin results in more patients with improved or resolved MASH without worsening of fibrosis, improved fibrosis without worsening of MASH
Residual Inflammation Seen in One-Third of Patients With Psoriasis on Biologics
Residual inflammation significantly linked to higher BMI, metabolic dysfunction-associated steatotic liver disease, baseline systemic inflammation
Metabolic Dysfunction-Linked Steatotic Liver Disease Tied to Increased Preterm Birth Risk
No increased risk seen for congenital malformation, stillbirth, or neonatal death
Simultaneous Liver Transplant, Sleeve Gastrectomy Beneficial
Results showed durable weight loss, resolution of diabetes and hypertension, and reduction in allograft steatosis
Study IDs Trends in 2015 to 2023 Mortality for Chronic Liver Disease
Increasing trend in metabolic dysfunction-associated steatotic liver disease-related mortality steeper than that for alcohol-related liver disease mortality
